Lupin 2024

NACDS expands Test2Learn pharmacogenomics tour

Print Friendly, PDF & Email

ARLINGTON, Va. — The National Association of Chain Drug Stores plans more stops for the national tour of the the Test2Learn Community-Based Pharmacogenomics Certificate Program.

NACDS said late Wednesday that the program, done in partnership with University of Pittsburgh School of Pharmacy, will come to Duke University in Durham, N.C., on April 10-11; Chapman University’s School of Pharmacy in Irvine, Calif., on April 27-28; and Ohio State University in Columbus, Ohio, on May 18-19. Additional tour stops for 2017 will be announced later this spring.

pharmacy signThe additional program dates stem from the positive outcomes and engagement in the initial phase of the Test2Learn pharmacogenomics certificate program, according to NACDS.

“We are providing community pharmacy with an education program that trains pharmacists to improve patient outcomes through a more personalized and tailored approach to medicine,” NACDS president and chief executive officer Steve Anderson said in a statement. “The inaugural Test2Learn tour generated a great deal of interest and positive feedback from participants and faculty, so we are delighted to be able to expand the tour to include additional locations in the Midwest, South and on the West Coast.”

Pharmacogenomics combines pharmacology and genomics to ensure that medications are used in a safe and effective manner based on a person’s genetic makeup. The certificate program enhances pharmacists’ skills using genetic test results to give individual patients the right medicine at the right dose.

NACDS and the University of Pittsburgh School of Pharmacy adapted Test2Learn from a university platform in which students use real genetic data in interactive exercises. Test2Learn teaches the principles of pharmacogenomics as well as its practical implications in disease states such as cardiology, oncology, neurology and infectious diseases, among others. It trains pharmacists to decipher genetic tests, translate that information and make appropriate recommendations for the patient, including clinical decision making, interpretation of patient results, and counseling and collaboration with prescribers to help optimize patient medication regimens.

The program is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Practice-based Continuing Pharmacy Education activity. The online home study module and the one-day live, in-person module total about 20 credit hours of pharmacogenomics educational content. Program participants have the opportunity to use an anonymous genomic data set, or their own personal data, for the in-person educational module. Faculty will include representatives of the University of Pittsburgh. Voluntary genetic testing is through the company 23andMe.


ECRM_06-01-22


Comments are closed.

PP_1170x120_10-25-21